Ganciclovir
Who holds supplier records for Ganciclovir? 5 organisations hold a current record for Ganciclovir: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Germany (1), India (1) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ganciclovir: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ganciclovir
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ganciclovir. Country is the organisation's recorded country, not necessarily the manufacturing site.
- EXCELLA GMBH AND CO KGGermanyCEP Company GMP cert on recordActive DMF 24337, 15567 · latest filing Nov 2010
- Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.ChinaCEPActive DMF 28973 · latest filing Apr 2015
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 31402 · latest filing Feb 2017
- TRIFARMA SPAItaly Company GMP cert on recordActive DMF 23721 · latest filing Apr 2010
- Zhejiang Charioteer Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordInactive DMF 27133 · latest filing May 2013
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Ganciclovir, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SHANGHAI PHARMA GROUP CHANGZHOU KONY PHARMACEUTICAL CO., LTD. Luoyang Town | CN | CEP 2024-086 - Rev 00 Ganciclovir | Sept 2025 | — |
| EXCELLA GMBH & CO. KG Feucht | DE | CEP 2010-257 - Rev 04 Ganciclovir, Anhydrous | Mar 2025 | Inspected Apr 2026 Germany |
| Zhejiang Charioteer Pharmaceutical Co., Ltd. Xianju | CN | R1-CEP 2013-123 - Rev 01 Ganciclovir | Jun 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Ganciclovir are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- India · Inactive DMF 19049 · filed Dec 2005
- RANBAXY LABORATORIES LTDInactive DMF 16043 · filed Jul 2002
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ganciclovir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL182).
Chemical identity
- IUPAC name
- 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one
- Canonical SMILES
- C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
- InChIKey
- IRSCQMHQWWYFCW-UHFFFAOYSA-N
- Synonyms
- BW 759U, BW-759U, Cymevene, Cytovene, Ganciclovir, Gancyclovir, Ganzyk-rtu, NSC-759656, RS-21592, Valganciclovir hydrochloride impurity a, Virgan, Vitrasert
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor; Nucleoside Analog Antiviral
- Mechanism of action
- DNA Polymerase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ganciclovir?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Ganciclovir: EXCELLA GMBH AND CO KG (Germany), Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. (China), APITORIA PHARMA PRIVATE LTD (India), TRIFARMA SPA (Italy) and Zhejiang Charioteer Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ganciclovir Drug Master Files are active?
EXCELLA GMBH AND CO KG (DMF 24337, 15567), Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. (DMF 28973), APITORIA PHARMA PRIVATE LTD (DMF 31402) and TRIFARMA SPA (DMF 23721). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ganciclovir records mean?
2 organisations have only inactive Type II DMFs for Ganciclovir. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ganciclovir have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Ganciclovir on the EDQM register, including SHANGHAI PHARMA GROUP CHANGZHOU KONY PHARMACEUTICAL CO., LTD. Luoyang Town (CN), EXCELLA GMBH & CO. KG Feucht (DE) and Zhejiang Charioteer Pharmaceutical Co., Ltd. Xianju (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ganciclovir supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ganciclovir?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.